Archis Pharma LLC Sustainability Profile
Archis Pharma LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in innovative drug development and manufacturing. Founded in 2008, the company has established itself as a leader in providing high-quality pharmaceutical products, particularly in the areas of oncology and rare diseases. With a commitment to advancing healthcare, Archis Pharma offers a unique portfolio of services, including custom synthesis and formulation development, tailored to meet the specific needs of its clients. The company’s focus on quality and regulatory compliance has earned it a strong market position, recognised for its contributions to improving patient outcomes. Through strategic partnerships and a dedication to research, Archis Pharma continues to drive innovation in the pharmaceutical landscape.
DitchCarbon Score
How does Archis Pharma LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Archis Pharma LLC's score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Archis Pharma LLC's reported carbon emissions
Archis Pharma LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Archis Pharma may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, Archis Pharma's future climate commitments will be crucial for aligning with broader environmental goals.
How Carbon Intensive is Archis Pharma LLC's Industry?
How Carbon Intensive is Archis Pharma LLC's Location?
Archis Pharma LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Archis Pharma LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
